Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  London Stock Exchange  >  Shire PLC    SHP   JE00B2QKY057

SHIRE PLC (SHP)

Delayed Quote. Delayed  - 05/26 05:35:09 pm
4651.5 GBp   -1.83%
05/29 British shares up 0.4 Friday
05/24 FTSE edges up helped by M&S, but miners weigh
05/23 SHIRE : Blocklisting - Interim Review
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

Shire PLC : Shire Buys 50,953 Own Shares to Hold in Treasury

share with twitter share with LinkedIn share with facebook
share via e-mail
0
02/22/2013 | 09:57am CEST

LONDON--Biopharmaceutical company Shire PLC (SHP.LN), said Friday it purchased 50,953 of its ordinary shares of 5 pence each on February 21, through both direct purchases of Ordinary Shares and through the purchase of Ordinary Shares underlying ADRs.

MAIN FACTS:

-The purchased shares will be held as treasury shares

-The highest and lowest price paid for the directly acquired Ordinary Shares was 2083.00 pence per share and 2047.00 pence per share respectively and for those Ordinary Shares acquired through the purchase of ADRs was 3148.50 cents per share and 3139.33 cents per share respectively.

-Shire shares at 0840 GMT traded up 5.0 pence, or 0.2%, at GBP20.77, valuing the company at GBP11.55 billion.

-Write to Razak Musah Baba at [email protected]

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on SHIRE PLC
05/29 British shares up 0.4 Friday
05/24 FTSE edges up helped by M&S, but miners weigh
05/23 SHIRE PLC : Financial Statements and Exhibits (form 8-K)
05/23 SHIRE : Blocklisting - Interim Review
05/19 SHIRE PLC : Blog Coverage: Shire's Stock Price Jumped on Positive Results in Her..
05/19 SHIRE : What the other papers say this morning
05/18 SHIRE PLC (NASDAQ : SHPG) Files An 8-K Other Events
05/18 SHIRE PLC : Financial Statements and Exhibits (form 8-K)
05/18 SHIRE : The Lancet Publishes Phase 2 Results from Shire’s Investigational ..
05/18DJSHIRE : Reports Positive Data For Angiodema Drug
More news
Sector news : Pharmaceuticals - NEC
05/29 WARREN BUFFETT : Warren Buffett takes 3 percent stake in Germany's Lanxess
05/29DJMERCK : Congo Approves Anti-Ebola Vaccine to Combat Outbreak in Remote Northeast
05/26DJSUN PHARMACEUTICAL INDUSTRIES : Pharma 4Q Profit Falls 13.6%
05/24 JOHNSON & JOHNSON : J&J settles drug manufacturing probe by U.S. states for $33 ..
05/24 FTSE edges up helped by M&S, but miners weigh
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
05/26 Tracking Stephen Mandel's Lone Pine Capital Portfolio - Q1 2017 Update
05/25 Tracking Larry Robbins's Glenview Capital Management Portfolio - Q1 2017 Upda..
05/23 SHIRE (SHPG) : Positive Topline Phase 3 Results for Lanadelumab (SHP643) in Pati..
05/23 Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q1 2017 Update
05/22 Shire Is Poised To Dominate The HAE Market After Strong Phase III Data For SH..
Advertisement
Financials ($)
Sales 2017 15 193 M
EBIT 2017 5 799 M
Net income 2017 2 736 M
Debt 2017 18 729 M
Yield 2017 0,63%
P/E ratio 2017 17,48
P/E ratio 2018 12,79
EV / Sales 2017 4,79x
EV / Sales 2018 4,21x
Capitalization 54 018 M
More Financials
Chart SHIRE PLC
Duration : Period :
Shire PLC Technical Analysis Chart | SHP | JE00B2QKY057 | 4-Traders
Full-screen chart
Technical analysis trends SHIRE PLC
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 24
Average target price 73,8 $
Spread / Average Target 24%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Flemming Ornskov Chief Executive Officer & Executive Director
Susan Saltzbart Kilsby Non-Executive Chairman
Jeffrey Poulton Chief Financial Officer & Executive Director
Philip J. Vickers Global Head-Research & Development
Matt Walker Head-Technical Operations
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
SHIRE PLC-0.69%54 596
JOHNSON & JOHNSON10.16%341 901
ROCHE HOLDING LTD.14.62%236 581
NOVARTIS AG6.07%211 457
PFIZER INC.-1.05%191 398
MERCK & CO., INC.10.28%177 567
More Results